Japan Chemical Daily

Japan's leading chemical industry newspaper

Log In

LSII Moves Toward Commercial Production of Muse Cells

Filed Under: Industry, Pharma Tagged With: , , ,

Mitsubishi Chemical Holdings Corp. (TYO:4188) subsidiary Life Science Institute Inc. (LSII) is embarking on commercial production of Muse cells, which…...

Please subscribe to read the full story.

Subscribe Free Trial

Related Articles:

LSII to Launch Clinical Trials of Muse Cells to Treat Respiratory Failure in COVID-19 Patients
LSII to Launch Clinical Trials of Muse Cells to Treat…
Nissan Chemical Eyes Global Expansion of High-Performance, Cost-Effective Cell Culture Supplement
Nissan Chemical Eyes Global Expansion of High-Performance,…
Tosoh Enables Simple Removal of Regenerative Medicine Cells Using New Thermoresponsive Polymer
Tosoh Enables Simple Removal of Regenerative Medicine Cells…
Sekisui Chemical Moves Into Cell Culture Sector
Sekisui Chemical Moves Into Cell Culture Sector
Mitsubishi Chemical to Produce Regenerative Medicine Materials From Plants
Mitsubishi Chemical to Produce Regenerative Medicine…
AGC Plans to Invest Over 200B Yen in CDMO Operations for Gene & Cell Therapy, More
AGC Plans to Invest Over 200B Yen in CDMO Operations for…